Liposomal annamycin

Liposomal annamycin
Trade Name
Orphan Indication Acute myeloid leukemia
USA Market Approval USA
USA Designation Date 2005-06-17 00:00:00
Sponsor Callisto Pharmaceuticals, Inc.;420 Lexington Avenue;New York, New York, 10170
Related Access Program
Children’s Hospital Los Angeles – Acute myeloid leukemia Jazz Pharmaceuticals – Secondary AML Celator Pharmaceuticals – Secondary AML University of California, San Francisco – Acute myeloid leukemia Emory University – Acute myeloid leukemia